DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
P•• M••••• T•••• L••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: LLC PAI Co-Investor FT Aggregator LLC; LLC Undrawn Commitment
Principal held
at least $58.8M
sum of BDC pieces, a lower bound
Fair value
$53.6M
99c on cost, debt pieces
Unfunded
$3.9M
commitments not yet drawn
BDC lenders
5
4 on the latest quarter
Facilities
3
2 equity pieces beside them
Next maturity
Feb 13, 2032
no dated debt inside 24 months
On the tape since
Mar 31, 2025
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $55.0M | 99c | SOFR+475 bp | Feb 13, 2032 | 4 |
| first lien revolver first lien | at least $3.8M | n/a | SOFR+50 bp | Feb 13, 2032 | 4 |
| revolver lien unstated exited Mar 31, 2025 | unknown | n/a | unstated | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A••••• D••• S•••••••• B•• | term loan first lien Investment T••• F•••• L••• S•••••• D••• - T••• L••• I••••••• R••• S+475, 0.75% F•••• M•••• | $29.5M | $28.4M 98c | SOFR+475 bp |
| A••••• D••• S•••••••• B•• | revolver first lien Investment T••• F•••• L••• S•••••• D••• – R••••••• I••••••• R••• S+450, 0.75% F•••• M••••• | Not disclosed | $-185,000 289c | SOFR+450 bp |
| M••••• A••••• I••••••••• P•••••• L•••••• | unstated lien unstated | Not disclosed | Not disclosed | |
| M••••• C•••••• I••••• P••• C••• | revolver first lien R•••••••) | S••••• S•••••• L•••• | $3.8M | $0 | S+475 bp |
| M••••• C•••••• I••••• P••• C••• | revolver first lien R•••••••) | Not disclosed | Not disclosed | |
| M••••• C•••••• I••••• P••• C••• | term loan first lien S••••• S•••••• L•••• | $17.6M | $17.5M 101c | S+475 bp |
| S•••••••• P•••••• C••••• F••• L•• | term loan first lien T••• L••• | N••• D••• Inv. | F•••• L••• S••••• S•••••• L••• | $4.0M | $3.9M 100c | SOFR+475 bp |
| S•••••••• P•••••• C••••• F••• L•• | revolver first lien R•••••••• Credit L••• | N••• D••• Inv. | F•••• L••• S••••• S•••••• L••• | 2/13/2032 | $0 | $0 0c | SOFR+50 bp |
| S•••••••• P•••••• C••••• F••• L•• | term loan first lien T••• L••• | N••• D••• Inv. | F•••• L••• S••••• S•••••• L••• | 2/13/2032 | $305,000 | $301,000 100c | SOFR+475 bp |
| S•••••••• P•••••• C••••• F••• L•• | term loan first lien T••• L••• | N••• D••• Inv. | F•••• L••• S••••• S•••••• L••• | 2/13/2032 One | $3.7M | $3.6M 100c | SOFR+475 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 4 | $58.8M | $53.6M | 99c | 0 |
| Mar 31, 2026 | 4 | $59.6M | $55.3M | 100c | 0 |
| Dec 31, 2025 | 4 | $63.2M | $59.7M | 101c | 0 |
| Sep 30, 2025 | 4 | $54.2M | $50.1M | 101c | 0 |
| Jun 30, 2025 | 4 | $61.7M | $57.2M | 100c | 0 |
| Mar 31, 2025 | 5 | $61.7M | $57.0M | 100c | 0 |
What changed
- Spread changed (observed)Jun 30, 2026
- Spread increasedJun 30, 2026
- Marked down across lendersMar 31, 2026
- Marked down (one lender)Mar 31, 2026
- Lender left a facilityJun 30, 2025
- Lender left a facilityJun 30, 2025
- New borrower on a BDC scheduleMar 31, 2025
- Facility left every BDC scheduleMar 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- P•• M••••• T•••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 5 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it